ARLINGTON, Va. — HDA president and CEO Chester “Chip” Davis, Jr., released a statement commenting on passage of the COVID-19 emergency relief package by the U.S. House of Representatives and the U.S. Senate. “HDA applauds Congress for passing the bipartisan economic stimulus package that will provide much needed relief to the businesses and millions of
ARLINGTON, Va. — HDA president and CEO Chester “Chip” Davis, Jr., released the following statement on the U.S. Food and Drug Administration’s (FDA) decision to grant Emergency Use Authorization of the first COVID-19 vaccine, manufactured by Pfizer and BioNTech: “Today’s decision by the FDA marks a historic turning point in the fight against this global
ARLINGTON, Va. — A survey released today by the Healthcare Distribution Alliance (HDA) Research Foundation indicates the pharmaceutical supply chain continues to make steady progress to comply with the 2013 Drug Supply Chain Security Act (DSCSA); however, some implementation priorities have shifted amid the initial industry response to the COVID-19 pandemic. The Serialization Readiness Survey, released in conjunction
ARLINGTON, Va. — A report published by the Healthcare Distribution Alliance (HDA) Research Foundation and Deloitte Consulting found that during the first 90 days of the COVID-19 pandemic, the biopharmaceutical finished goods industry quickly adapted and adjusted to deliver medicines safely and efficiently to patients, with only minimal disruptions. As noted in the report, The First
ARLINGTON, Va. — HDA’s Pharmaceutical Cargo Security Coalition recognized three outstanding supply chain security professionals today through the annual PCSC Awards. Presented virtually as part of the PCSC Online Seminar, the awards honor leaders who demonstrate the highest standards of honesty and integrity, while undertaking extraordinary efforts to serve and protect their communities. The 2020 honorees
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) today announces the election of Robert Mauch, EVP and group president of AmerisourceBergen Corp., as chairman of the HDA board of directors. Chad Gielen, president/CEO of Louisiana Wholesale Drug Co., will serve as vice chairman. Mauch, who served as HDA vice chairman for two years, assumes Board
ARLINGTON, Va. — HDA and its distributor-member companies continue to work with partners across the pharmaceutical supply chain and public sector in response to COVID-19. Below are new resources that provide insight into our industry’s efforts: HDA Principles for Pandemic and Public Health Emergency Response: Released on June 11, HDA reaffirmed the industry’s commitment to assisting
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) released policy principles reaffirming the pharmaceutical distribution industry’s commitment to assisting the country and frontline healthcare providers during pandemics and public health emergencies. HDA highlights four priority areas: Supply Chain Coordination: Coordination between the public and private sector is key to addressing public health crises. Accordingly, a consolidated contact within the
ARLINGTON, Va. — Taking on a new leadership role is never easy; taking the helm during a global pandemic, however, especially when job No. 1 for the organization’s members involves keeping the country’s vital medical supply chain running smoothly, defines daunting. But being named president and chief executive officer of the Healthcare Distribution Alliance
ARLINGTON, Va. — HDA has released a two-minute video that further reinforces the pharmaceutical distribution industry’s critical function as it adapts and rises to the challenge of COVID-19, while also continuing the vital work of delivering the medicines Americans rely on to manage their daily health care needs. The video features HDA president and CEO
Across the country, brave, frontline health care professionals are working around the clock as our nation grapples with the COVID-19 pandemic. These workers — the true heroes of the pandemic — are treating patients, maintaining vital health care operations and serving as emergency responders. In this time of crisis, it is also important to remember
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) board of directors’ executive committee announced Monday the appointment of Chester “Chip” Davis, to the position of president and chief executive officer. Davis will join HDA during March of this year. He joins HDA coming from the Association for Accessible Medicines (AAM), the nation’s leading trade association
A new decade presents an opportunity for reflection. For Healthcare Distribution Alliance and our pharmaceutical distributor members, 2020 finds us reexamining the value our industry provides to the larger health care ecosystem while reassessing our priorities and anticipating what is around the corner. HDA captured the state of our industry, and what the future may
MAPLE GROVE, Minn. – Upsher-Smith announced that it has been honored with two Distribution Industry Awards for Notable Achievement in Healthcare (DIANAs) for “Overall Manufacturer of the Year with sales less than $500 Million” and “Branded Pharmaceutical Product Manufacturer of the Year with sales less than $300 Million” by the Healthcare Distribution Alliance (HDA). The
